IPP Bureau
Aster Hospital opens 100-bed multi-specialty facility in Sharjah
By IPP Bureau - October 21, 2022
The newest facility has all the core specialties like Obstetrics and Gynaecology, Orthopaedics, Neurology, Cardiology, Paediatrics, General Surgery, and Urology
Lupin launches Paliperidone Extended-Release Tablets in US
By IPP Bureau - October 21, 2022
Paliperidone Extended-Release Tablets (RLD Invega) had estimated annual sales of US $112 million in the US
Aarti Drugs Q2 FY23 revenue up 19%; Profit down 5.6%
By IPP Bureau - October 21, 2022
Around 62% of the revenues came from the domestic market and 38% from the exports market for Q2 FY23 for a standalone business
Cadila Pharma's Esiloc wins "Best Launch of the Year"
By IPP Bureau - October 21, 2022
Esiloc was launched at the biggest doctor engagement webinar involving more than 12,000 doctors across the country
Lupin to acquire two inhalation brands from Sunovion for US$75 million
By IPP Bureau - October 20, 2022
The acquisition of these two brands expands Lupin's portfolio of inhalation products in the U.S.
Parexel bags Global Customer Value Leadership Award
By IPP Bureau - October 20, 2022
The award recognizes Parexel for delivering the best decentralized trial experience for customers through its capabilities, expertise, and patient recruitment and retention strategies
Health Minister Mandaviya inaugurates CGHS Wellness Centres
By IPP Bureau - October 20, 2022
CGHS would give robust coverage to pensioners and with new innovations and practices
MedScapeIndia launches a poster of 'Girl Child Anthem'
By IPP Bureau - October 20, 2022
The girl child anthem will portray a celebration of a girl child.
Syngene Q2 FY23 PAT up 11% to Rs. 102 Cr
By IPP Bureau - October 20, 2022
Revenue from operations up 26% to Rs. 768 crores
USFDA visit to Alembic Pharmaceuticals Panelav facility
By IPP Bureau - October 19, 2022
None of the observations are related to data integrity and Alembic Pharmaceuticals management believes that they are addressable
NHA join hands with NABH to expedite implementation of ABDM
By IPP Bureau - October 19, 2022
NABH shall encourage and provide assistance in onboarding their accredited/certified facilities on ABDM’s Health Facility Registry
Mandaviya directs officials to focus on strengthening genome sequencing for early detection of variants
By IPP Bureau - October 19, 2022
He also highlighted the need for community awareness for continued implementation of the Covid Appropriate Behaviour (CAB) especially in view of the upcoming festival season
AIIA organises multi-cultural dance competition for Ayurveda Day 2022
By IPP Bureau - October 19, 2022
Inceptua Early Access and Sentynl Therapeutics launch early access program for Nulibry for pediatric patients
By IPP Bureau - October 19, 2022
MoCD Type A is a rapidly progressive autosomal recessive inborn error of metabolism resulting in toxic sulfite levels causing neurologic sequelae
Merck and the Bill & Melinda Gates Medical Research Institute announce licensing agreement for tuberculosis antibiotic candidates
By IPP Bureau - October 19, 2022
The TBDA is a collaboration established among biopharmaceutical companies, research organizations and universities to accelerate the discovery and development of novel therapeutic candidates against TB.
